21 May 2013
Keywords: report, says, novo, merck, top, metabolism, market
Article | 12 January 2009
Danish diabetes specialist Novo Nordisk will remain the leading company in the metabolism sector in 2014 based on its broad insulin ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
20 May 2013
© 2013 thepharmaletter.com